Sorry, you need to enable JavaScript to visit this website.

This website is intended for healthcare professionals in KSA and UAE only.

The content provided is developed in accordance with local regulations and may not be applicable or compliant in other regions.

This website is intended for healthcare professionals in KSA and UAE only.
 The content provided is developed in accordance with local regulations and may not be applicable or compliant in other regions.

Reporting adverse events
Reporting adverse events
CSL_Logo
Log in
Icon Search
hamburguer menu

Search results

hamburguer menu
Log in
Submitted by Site Factory admin on
Proteinuria

The combined effect of endothelin-1 (ET-1) and angiotensin II (ANG II) in IgA Nephropathy (IgAN)

Watch this video to find out more about how ET-1 and ANG II are involved in the pathophysiology of IgAN.

Play video
icon arrow right
Video

Report adverse events in the UK


Adverse events should be reported. Reporting forms and
information for United Kingdom can be found at https://
yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the
Google Play or Apple App Store. Adverse events should also be
reported to Vifor Pharma Ltd. Tel: +44 1276 853633. E-
mail: medicalInfo_UK@viforpharma.com

Help us guide you to the right place

audience-Icon

I am a KSA & UAE health
care professional or KSA & UAE
healthcare decision
maker

This is me, continue
icon-arrow-right
audience-Icon

I am not a KSA & UAE health
care professional or KSA & UAE
healthcare decision
maker

This is me, continue
icon-arrow-right